← Open Payments lookup

TETYANA EVANS: Open Payments

NPI 1285927723 · PASADENA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,019 in 55 payments from 14 companies in 2025. Trend: 2023 $63 · 2024 $573 · 2025 $1,019

Food & beverage: $1,010Education: $9
CompanyPaymentsAmount
ABBVIE INC.15$154
Alkermes, Inc.9$139
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$139
Indivior Inc.4$113
Supernus Pharmaceuticals, Inc.5$103
Neurocrine BioSciences, Inc.3$78
Teva Pharmaceuticals USA, Inc.2$60
Lundbeck LLC3$55
E.R. Squibb & Sons, L.L.C.2$48
Janssen Pharmaceuticals, Inc2$39

Products named: VRAYLAR, CAPLYTA, SUBLOCADE, ARISTADA, Qelbree, INGREZZA, AUSTEDO XR, REXULTI.

Industry payments across MD — which companies pay providers there.